Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025
Compare Balance Sheet Results of Goldline Pharmac
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.71
13.42
-4.71
-35.10%
Share Warrants & Outstandings
Total Reserve
5.54
53.39
-47.85
-89.62%
Shareholder's Funds
14.25
66.81
-52.56
-78.67%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.21
13.34
-10.13
-75.94%
Secured Loans
0.66
3.12
-2.46
-78.85%
Unsecured Loans
2.55
10.22
-7.67
-75.05%
Deferred Tax Assets / Liabilities
-0.08
-1.23
1.15
93.50%
Other Long Term Liabilities
1.04
2.04
-1.00
-49.02%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
1.11
-1.11
-100.00%
Total Non-Current Liabilities
2.43
15.26
-12.83
-84.08%
Current Liabilities
Trade Payables
1.85
55.42
-53.57
-96.66%
Other Current Liabilities
2.56
15.31
-12.75
-83.28%
Short Term Borrowings
7.70
54.47
-46.77
-85.86%
Short Term Provisions
0.00
0.17
-0.17
-100.00%
Total Current Liabilities
12.11
125.37
-113.26
-90.34%
Total Liabilities
28.79
207.44
-178.65
-86.12%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.76
86.49
-82.73
-95.65%
Less: Accumulated Depreciation
1.06
36.32
-35.26
-97.08%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.71
50.17
-47.46
-94.60%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.03
3.52
-3.49
-99.15%
Long Term Loans & Advances
0.02
0.48
-0.46
-95.83%
Other Non Current Assets
0.00
4.24
-4.24
-100.00%
Total Non-Current Assets
2.75
60.87
-58.12
-95.48%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.21
37.84
-31.63
-83.59%
Sundry Debtors
16.13
64.96
-48.83
-75.17%
Cash and Bank
0.59
3.55
-2.96
-83.38%
Other Current Assets
1.13
1.13
0.00
0.00%
Short Term Loans and Advances
1.98
39.08
-37.10
-94.93%
Total Current Assets
26.05
146.57
-120.52
-82.23%
Net Current Assets (Including Current Investments)
13.93
21.19
-7.26
-34.26%
Total Current Assets Excluding Current Investments
26.05
146.57
-120.52
-82.23%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.79
207.44
-178.65
-86.12%
Contingent Liabilities
3.37
4.05
-0.68
-16.79%
Total Debt
7.41
67.80
-60.39
-89.07%
Book Value per share (adjusted)
18.03
50.88
-32.85
-64.56%
Annual - Borrowings
Borrowings 9.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.04 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Annual - Fixed Assets
Fixed Assets 2.71 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Annual - Investments
Investments 0.03 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 26.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025
